2013
DOI: 10.1016/j.ijmedinf.2012.11.008
|View full text |Cite
|
Sign up to set email alerts
|

Secondary use of routinely collected patient data in a clinical trial: An evaluation of the effects on patient recruitment and data acquisition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
43
0
2

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 34 publications
(45 citation statements)
references
References 13 publications
0
43
0
2
Order By: Relevance
“…The effect seemed to correlate with an increase in screening efficiency that similarly doubled the number of screened patients. A comparatively minor increase in recruited patients of 14% from 306 to 348 in the same week was reported by Köpcke et al [69] who addressed pure oversight of otherwise well-organized manual recruiters. They also found 7% of the manually included patients did not fulfill the trial’s eligibility criteria.…”
Section: Resultsmentioning
confidence: 71%
See 2 more Smart Citations
“…The effect seemed to correlate with an increase in screening efficiency that similarly doubled the number of screened patients. A comparatively minor increase in recruited patients of 14% from 306 to 348 in the same week was reported by Köpcke et al [69] who addressed pure oversight of otherwise well-organized manual recruiters. They also found 7% of the manually included patients did not fulfill the trial’s eligibility criteria.…”
Section: Resultsmentioning
confidence: 71%
“…The latter is generally the case for retrospective trials and feasibility studies. Typical examples include Payne et al [97], Thadani et al [115], and Köpcke et al [69] who required an administrator to develop a Structured Query Language (SQL)-based query. Based on 16 years of COSTAR research queries, Murphy [85] created the graphical interface Informatics for Integrating Biology and the Bedside (i2b2) to allow investigators to parameterize query templates themselves.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…As an increased amount of data is produced in EHRs, the of data gathered in process of providing care for reseach is re-used to facilitate patient identification for new clinical trials [3,7], to collect care data within clinical research setting [5] or to be combined with DNA biorepositories for identifying accurately phenotyped cases and controls for large-scale genomic studies [12] or to conduct pharmacogenetic studies [14,15]. Utilizing the availability of patient data from federated EHR systems in many different sites, as well as in international multilingual settings is still challenging [2].…”
Section: Discussionmentioning
confidence: 99%
“…While data collection in care settings should ideally permit data reuse for epidemiology, public health, or research, it is still difficult to reuse the data produced in care setting. 28 In this context, several standards are available to support the recording of health data in health information systems. They have been developed to standardize either DEs and information models (Health Level Seven (HL7), 29 OpenEHR (EN 13606) 30 ), value sets or terminologies (LOINC, 31 SNOMED CT 32 for clinical terms, Orphanet 1 for orphan drugs and rare disease diagnosis, Human Phenotype Ontology (HPO) 33 for signs, Online Mendelian Inheritance in Man (OMIM) 34 for genes, Human Genome Variation Society (HGVS) Mutnomen, 35 and GenATLAS 36 38 to support interoperability between CDISC (clinical research) and HL7 (electronic health records).…”
Section: Interoperability and Standardsmentioning
confidence: 99%